Core One Labs’ Vocan Initiates Engineering and Design of a Proprietary Production System for Manufacturing of API-Grade DMT
April 21, 2021
Ryan Allway April 21st, 2021 Psychedelics VANCOUVER, British Columbia, April 21, 2021 (GLOBE NEWSWIRE) — Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (”Core One”) a life sciences research and technology company focused on bringing psychedelic medicines to market through novel delivery systems and psychedelic-assisted psychotherapy is... Read more
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any... Read more
KI findet die Nadel im Heuhaufen
April 15, 2021
Makenzie Branch April 15th, 2021 Exclusive, German, Psychedelics Jedes Jahr werden Tausende von Molekülen als Medikamentenkandidaten für eine Vielzahl von Krankheiten hergestellt, synthetisiert und getestet. MagicMed Industries bringt diesen pharmazeutischen Entwicklungsansatz auf dem Gebiet der Psychedelika zum Einsatz, um neue therapeutische Alternativen für Patienten mit Problemen der Gehirn- und... Read more
PharmaTher Provides Update on Psychedelic Product Programs
April 15, 2021
Ryan Allway April 15th, 2021 Psychedelics TORONTO, April 15, 2021 (GLOBE NEWSWIRE) — PharmaTher Holdings Ltd. (“PharmaTher”) (CSE: PHRM) (OTCQB: PHRRF), a specialty psychedelic pharmaceutical company, is pleased to provide an update on its psychedelic product programs as it relates to the clinical and commercial development of ketamine and... Read more
Silo Wellness Announces Intellectual Property Licensing Agreement of Psilocybin Nasal Spray in Colombia and Brazil
April 15, 2021
Ryan Allway April 15th, 2021 Psychedelics TORONTO, April 15, 2021 (GLOBE NEWSWIRE) — Silo Wellness Inc. (“Silo Wellness”) (CSE: SILO) (FRA:3K70), a wellness company in the psychedelics and functional mushroom marketplaces announced today that through its wholly-owned subsidiary, it has signed a binding Letter of Intent (LOI) for a... Read more
AI to Find Needle in Haystack
April 15, 2021
Makenzie Branch April 15th, 2021 App, Exclusive, Psychedelics, Top Story Every year, thousands of molecules are being created, synthesized and tested as drug candidates for a vast number of ailments. MagicMed Industries brings this pharmaceutical development approach to the field of psychedelics to create new therapeutic alternatives for patients... Read more
Optimi Health Adds to Corporate and Advisory Team
April 14, 2021
Ryan Allway April 14th, 2021 Psychedelics VANCOUVER, BC (GLOBE NEWSWIRE – April 14, 2021) — Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated functional mushroom brand focused on the health and wellness sector, is pleased to announce the appointments of Dr.... Read more
Ryan Allway April 14th, 2021 App, Exclusive, Psychedelics, Top Story Psychedelics have become one of the most promising classes of drugs in a generation, as well as an exciting new industry for investors. Despite their resurgence among researchers and investors, psychedelics have been used for thousands of years before... Read more
Former GW Pharmaceuticals CFO joins Beckley Psytech’s Board
April 13, 2021
Ryan Allway April 13th, 2021 Psychedelics Beckley Psytech, a private company dedicated to addressing neurological and psychiatric disorders through psychedelic medicine, has appointed ex-GW Pharmaceuticals CFO Adam George as a director with immediate effect. Bringing nearly two decades of experience in the pharmaceuticals industry, Adam served as Chief Financial... Read more
Psychedelic Wellness-Focused Company Delic Holdings Provides First Quarter 2021 Shareholder Update
April 12, 2021
Ryan Allway April 12th, 2021 Psychedelics, Top News VANCOUVER, BC, April 12, 2021 /PRNewswire/ – Delic Holdings Inc. (“DELIC” or the “Company“) (CSE: DELC) (OTCQB: DELCF), a psychedelic wellness-focused company, is pleased to provide the following shareholder update on its operations for the first quarter of 2021. The first quarter of 2021... Read more
